Understanding Celiac Sprue (Celiac Disease, Nontropical Sprue, Gluten-Sensitive Enteropathy) diagnosis, symptoms, and treatment is crucial for healthcare professionals. This resource provides information on clinical documentation, medical coding, and ICD codes related to Celiac Disease for accurate and efficient healthcare data management. Learn about the connection between gluten sensitivity and enteropathy in Celiac Sprue, along with best practices for diagnosis and patient care. Explore relevant medical terminology and coding guidelines for optimal clinical documentation and healthcare information exchange.
Autoimmune disorder triggered by gluten ingestion, damaging the small intestine.
Diarrhea, abdominal pain, bloating, weight loss, fatigue. Dermatitis herpetiformis can also occur.
Gastroenterology clinics, primary care offices, dietitian consultations, pediatric clinics.
Complete code families applicable to K90.0
| Description | When to use |
|---|---|
| Autoimmune reaction to gluten | Confirmed by serology and/or biopsy showing damage to small intestine due to gluten ingestion. |
| Gluten intolerance, no autoimmune reaction | Symptoms similar to celiac sprue but serology and biopsy negative. Improvement on gluten-free diet. |
| Wheat allergy, often immediate reaction | Symptoms such as hives, itching, swelling after wheat ingestion. IgE mediated immune response to wheat proteins. |
Using unspecified sprue codes (K90.8) when Celiac is confirmed leads to lower reimbursement and data inaccuracy.
Insufficient documentation of DHHS criteria for Celiac Sprue diagnosis impacts medical necessity reviews and compliance.
Discrepancies between clinical findings, serology, and biopsy results for Celiac Sprue complicate coding and audit validation.
Confirm gluten ingestion history ICD-10-CM: K90.0
Check for diarrhea, bloating, fatigue SNOMED CT: 6789002
Order tissue transglutaminase IgA LOINC: 26443-9
Consider HLA-DQ2/DQ8 genetic testing ICD-10-CM: Z13.82
Evaluate small intestine biopsy if positive serology SNOMED CT: 125027007
Patient presents with complaints consistent with celiac disease, also known as celiac sprue or gluten-sensitive enteropathy. Symptoms reported include chronic diarrhea, abdominal pain, bloating, and weight loss. The patient also notes fatigue and iron deficiency anemia diagnosed on previous laboratory testing. Family history is positive for autoimmune disorders, increasing the suspicion for celiac sprue. Differential diagnosis includes irritable bowel syndrome, inflammatory bowel disease, and other malabsorption syndromes. To confirm the diagnosis of celiac disease, serological testing for tissue transglutaminase IgA antibodies and endomysial antibodies will be ordered. If these are positive, a small bowel biopsy via esophagogastroduodenoscopy is indicated to assess for villous atrophy, the hallmark finding of celiac sprue. Depending on the biopsy results and severity of symptoms, the treatment plan will focus on a strict gluten-free diet, nutritional counseling, and monitoring for complications such as refractory celiac disease and associated malignancies. Patient education regarding gluten avoidance and long-term management of celiac disease will be provided. ICD-10 code K90.0 will be used for celiac disease, and CPT codes for the serological testing and endoscopy will be documented accordingly. Follow-up appointment scheduled in 4 weeks to review test results and discuss management strategies.
While tissue transglutaminase IgA (tTG-IgA) is often the first-line serological test for celiac disease, its sensitivity can be reduced in patients with IgA deficiency. For adults with suspected gluten-sensitive enteropathy, the most specific and sensitive approach involves combining tTG-IgA with total IgA levels. If IgA deficiency is present, IgG-based serological tests like deamidated gliadin peptide IgG (DGP-IgG) and tissue transglutaminase IgG (tTG-IgG) should be considered. Additionally, endomysial antibody (EMA) testing, though less commonly used due to cost and subjectivity, offers high specificity. It's crucial to remember that serological tests are not diagnostic on their own and must be interpreted in the context of the patient's clinical presentation and dietary history. Explore how combining serological tests can improve diagnostic accuracy in complex celiac disease cases.
Differentiating celiac disease from IBS and NCGS requires a multifaceted approach. While symptom overlap exists, key distinctions lie in the underlying pathophysiology. Celiac disease involves an autoimmune response to gluten, leading to villous atrophy in the small intestine, whereas IBS is a functional disorder without structural changes. NCGS, also distinct from celiac disease, lacks the characteristic autoimmune markers and intestinal damage. A thorough patient history, including family history of autoimmune disorders, alongside serological testing (tTG-IgA, total IgA, DGP-IgG) is essential for initial differentiation. Small bowel biopsy remains the gold standard for confirming celiac disease and ruling out other conditions. Consider implementing a structured diagnostic pathway for patients presenting with overlapping gastrointestinal symptoms to ensure accurate diagnosis and appropriate management. Learn more about the specific histological findings that differentiate celiac disease from other conditions.
Long-term management of celiac disease centers around strict adherence to a gluten-free diet, which is the cornerstone of therapy. This requires meticulous education on hidden sources of gluten and cross-contamination. Regular follow-up is essential to monitor for nutritional deficiencies (iron, vitamin B12, vitamin D, folate), bone health (osteoporosis), and the development of complications such as refractory celiac disease and enteropathy-associated T-cell lymphoma. Patients should be encouraged to engage with support groups and dietitians specializing in celiac disease for ongoing guidance and support. Monitoring should include periodic serological testing (e.g., tTG-IgA) to assess dietary compliance and evaluate for potential complications. Consider implementing a comprehensive patient education program that addresses the multifaceted aspects of long-term celiac disease management. Learn more about the latest guidelines on monitoring for long-term complications of celiac disease.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.